Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Is this AI stock still buyable, or already priced for perfection?
Michael Burry Sends Fresh Challenge to Palantir Bulls With 2027 Puts
The July Consumer Price Index lands Wednesday at 8:30 a.m. ET, and traders are hoping a soft number can reignite momentum in high-beta names like Palantir Technologies Inc. (NASDAQ:PLTR) and Tesla Inc. (NASDAQ:TSLA). Cato Institute economist Jai Kedia doubts it....
Micron's valuation has been falling in recent weeks as investors may be worried about the company's longer-term growth prospects.
Driven by explosive growth in non-traditional segments like AI compute hardware and Starlink, SpaceX is laying the groundwork for unprecedented scale.
The company is growing at an unprecedented rate, and everyone expects it to continue.
Laffer Tengler Investments CEO and CIO Nancy Tengler shares her thoughts on Palantir (PLTR) stock and why it's a buy.
Zeta Global (NYSE:ZETA) executives outlined the company’s strategy to consolidate marketing technology tools, expand adoption of its artificial intelligence products and pursue joint-selling opportunities through partnerships during KeyBanc’s Technology Leadership Forum in Park City, Utah. Chris Gr
Revenue surged 93% year over year as AI demand accelerated across U.S. markets.
Intel’s stock dropped 4%, weighing on the Nasdaq after announcing a $15 billion stock offering.
Famed "Big Short" investor Michael Burry buys new out-of-the-money puts on Palantir and adds to his Zoetis stake.
Palantir CEO Sounds Alarm on AI Spending: Are Businesses Paying Too Much?
Palantir's fantastic quarter wasn't enough to set a new all-time high.
Palantir Technologies (PLTR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Palantir just posted numbers that forced analysts to rethink what kind of company they are actually valuing, but the metric that defines the bull case also sets the exact threshold where the entire thesis falls apart.
(Bloomberg) -- Biotech company AbCellera Biologics Inc. jumped as much as 41%, giving it a market value of almost $3 billion, after it said a potential remedy for hot flashes was effective in a mid-stage trial.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’Stocks Churn as Oil Advance Boosts Treasury Yields: Markets WrapTrump Amps Up Pressure on Billionaire Sargeant to Exit VenezuelaBehind B
A sharp July jobs miss could ease rate-hike fears, while Palantir, SpaceX, Cerebras and NVIDIA show signs of AI stock stabilization.
Michael Burry just doubled down on his bearish AI bets even as semiconductors roar back, but one short in his portfolio stands out as a head-scratcher that may reveal a flaw in his entire thesis.
Palantir Technologies Inc. (NASDAQ:PLTR) has helped the Pentagon dramatically accelerate the process of finding targets in Iran, but a defense analyst says America’s ability to build the missiles needed to hit them hasn’t kept pace. Speaking to LBC on Sunday,...
Sands Capital, an investment management company, released its “Sands Capital Technology Innovators Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, global equities rebounded sharply, with the MSCI ACWI posting its strongest quarterly gain since 2020, supported by broad market strength, easing geopolitical tensions, and continued enthusiasm for […]
Archer Aviation holds an Olympic air taxi contract, a stack of blue-chip AI partnerships, and a clear FAA certification timeline, yet its shares sit closer to a 52-week low than a high. Something has to give, and the catalyst timeline is tighter than most investors realize.
According to the average brokerage recommendation (ABR), one should invest in Palantir Technologies (PLTR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
INOD's AI-driven growth accelerates as strong Q2 results, customer diversification and new solutions strengthen its long-term potential.
CEO Alex Karp said the AI titan delivered an "otherworldly" performance in the second quarter.
Vitalhub (TSE:VHI) reported second-quarter 2026 revenue of CAD 31.7 million, up 33% from the prior-year period, while annual recurring revenue surpassed CAD 100 million for the first time. Chief Financial Officer Brian Goffenberg said the company ended June with CAD 101.5 million in annual recurrin